IL2 and hemophilia A: Hemophilia A mice were treated with IL-2/IL-2mAb complexes+ rapamycin+anti-CD20+FVIII; IL-2/IL-2mAb complexes+ rapamycin+FVIII; anti-CD20+FVIII; and FVIII alone as described previously.